Profile of clinically-diagnosed dementias in a neuropsychiatric practice in Abeokuta, South-Western Nigeria

African Journal of Psychiatry (South Africa)

Volumn 14, Issue 5, 2011, Pages 377-381

  Amoo, G ^a   Akinyemi, R O ^b,e   Onofa, L U ^a   Akinyemi, J O ^c   Baiyewu, O ^d   Ogunlesi, A O ^a   Ogunniyi, A ^d  

^a Aro Neuropsychiatric Hospital   (Nigeria)

^b FEDERAL MEDICAL CENTER   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d UNIVERSITY OF IBADAN   (Nigeria)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Africa; BPSD; Dementia phenotypes; Neuropsychiatric practice; Nigeria

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; NEUROLEPTIC AGENT;

ADULT; AGED; AGITATION; ALCOHOL RELATED DEMENTIA; ALZHEIMER DISEASE; APATHY; ARTICLE; BEHAVIORAL AND PSYCHOLOGICAL SYMPTOM OF DEMENTIA; CLINICAL FEATURE; COMORBIDITY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HYPERTENSION; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MIXED DEMENTIA; MULTIINFARCT DEMENTIA; NEUROPSYCHIATRY; NIGERIA; PARKINSON DISEASE DEMENTIA; PHENOTYPE; SLEEP DISORDER; WANDERING BEHAVIOR;

AGE DISTRIBUTION; AGED; ANTIPSYCHOTIC AGENTS; COMORBIDITY; DEMENTIA; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIGERIA; PHENOTYPE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 84857811240     PISSN: 19948220     EISSN: None     Source Type: Journal    
DOI: 10.4314/ajpsy.v14i5.5     Document Type: Article

References (37)

1. Ogunniyi A, Akinyemi RO. Dementia in Africa - a review. Archives of Ibadan Medicine 2010; 10 (1&2): 40-46.
2. Osuntokun BO, Ogunniyi A, Junaid TA, Lekwauwa UG, Adeuja AOG, Bademosi O. Epidemiology of Dementia in Nigeria. In Chopra.J.S, Jagannathan K, Sawhney I.M.S, (eds) Advances in Neurology. Proceedings of the XIVth World Congress of Neurology October 20-27, 1989. New Delhi, India.331-342. Amsterdam. Excerpta Medica, 1990.
3. Osuntokun BO, Ogunniyi A. Epidemiology of Neurologic illness in Africa. Wemilore Press;1994: 36-39.
4. The Lancet Neurology Editorial. Time to confront the global dementia crisis. Lancet Neurol 2008; 7: 761.
5. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management and risk factors. Lancet Neurol 2008; 7: 812-826.
6. Ogunniyi A, Baiyewu O, Gureje O, Hall KS, et al. Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study. Euro. J. Neurol 2000; 7: 485-490.
7. Yusuf AJ, Baiyewu O, Sheikh TL, Shehu AU. Prevalence of dementia and dementia subtypes among community-dwelling elderly people in northern Nigeria. Int Psychoger 2010;18:1-8.
8. Ogunniyi AO, Lekwauwa UG, Falope ZF, Osuntokun BO. Clinically diagnosed dementing illness in Ibadan. Afr J Med Sci 1993; 22: 61-64.
9. Kayembe TK, Ngeleka CM, Kashama JM. Etiologic and Clinical Profiles of Dementia in Kinshasa. In Proceedings of the WHO-WFNIBRO Sponsored Meeting on "Brain Ageing and Dementia in Developing Countries" April 10-13, 2007.
10. Hersch EC, Falzgraf S. Management of the behavioural and psychological symptoms of dementia. Clinical Interventions in Aging 2007; 2 (4): 611 - 621.
11. Hwang J-P, Yang C-H, Tsai S-J, Liu K-M. Behavioural disturbances in psychiatric inpatients with dementia of the Alzheimer type in Taiwan. Int J Geriatr. Psychiatr 1997; 12: 902 - 906.
12. Ogunniyi A, Hall KS, Baiyewu O, Gureje O, Hendrie HC, Culture and Dementia. Brain Aging 2002; 2 (3): 23-29.
13. Baiyewu O, Smith-Gamble V, Akinbiyi A, Lane KA, Hall KS, Ogunniyi A, et al. Behavioural and caregiver reaction of dementia as measured by the neuropsychiatric inventory in Nigerian community residents. Int Psychogeriatr 2003; 15 (4): 399-409.
14. Jelic V, Winblad B. Treatment strategies in Alzheimer's disease. Brain Aging. 2002; 2 (3): 3-8.
15. World Health Organization: Manual for International classification of diseases, injuries and causes of death. 10th Revision. WHO: Geneva 1994.
16. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS - ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
18. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS - AIREN International Workshop. Neurology 1993; 43: 250-260.
19. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1993; 47: 1113 - 1124.
20. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1552.
21. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007; 22 (16): 2314-2324.
22. Cummings JL, Mega M, Gray K, Rosemberg-Thompson S, Carusi DA, et al. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308 - 2314.
23. Ogunniyi A, Akang EE, Gureje O, Takao M, Piccardo P, Baiyewu O, et al. Dementia with Lewy bodies in a Nigerian: a case report. Int Psychogeriatr 2002; 14 (2): 211-218.
24. Akinyemi RO, Owolabi MO, Makanjuola VA, Ogunseyinde AO, Ogunniyi A. Frontotemporal dementia in a Nigerian woman: case report and brief review of the literature. Afr J Med Med Sci 2009; 38: 71 - 75.
25. Ohaeri JU, Odejide OA. Admissions for drug and alcohol-related problems in Nigerian psychiatric care facilities in one year. Drug Alcohol Depend 1993 Jan;31(2):101-109.
26. Ihezue UH, Okpara E. Psychiatric disorders of old age in Enugu, Nigeria. Acta Psychr Scand1989;79: 332-337.
27. Akanji BO, Ogunniyi A, Baiyewu O. Healthcare for Older Persons, A country Profile: Nigeria. Journal Amer. Geriatr Society 2002; 50 (7): 1289-1292.
28. Ogunniyi A, Hall KS, Baiyewu O, Gureje O, Unverzagt FW, Gao S, Hendrie HC. Caring for individuals with dementia: the Nigerian experience. West Afr J Med 2005; 24 (3): 259-262.
29. Hendrie HC, Ogunniyi A, Hall KS, Incidence of dementia and Alzheimer's disease in two communities: Yoruba residing in Ibadan, Nigeria and African Americans residing in Indianapolis, Indiana. JAMA 2001; 285: 739-747.
30. Kalaria RN, Erkinjuntti T. Small vessel diseases of the brain. In: Lars-Olof Wahlund, Timo Erkinjuntti, Serge Gauthier (eds) Vascular cognitive impairment in Clinical Practice. Cambridge. Cambridge University Press.2009; 118 - 130.
31. Breteler MMB. Vascular risk factors for Alzheimer's disease: an epidemiological perspective. Neurobiol of Aging 2000; 21: 153-160.
32. Roberts RO, Geda YE, Knopman DS, Christianson TJH, Pankratz VS, Boeve BF et al. Association of Duration and Severity of Diabetes Mellitus with Mild Cognitive Impairment. Arch Neurol 2008; 65 (8): 1066-1073.
33. Duron E, Hanon O. Vascular risk factors, cognitive decline and dementia. Vasc Health Risk Manag 2008; 4(2):363-81.
34. Skoog I, Lithell H, Hansson L, et al. SCOPE Study Group. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens 2005; 18:1052-9.
35. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112-2117.
36. Ngandu T, von Strauss E, Helkala EL, Winblad B, Nissinen A, Tuomilehto J, et al. Education and dementia: what lies behind the association? Neurology 2007 Oct 2;69 (14):1442-50.
37. Zaudig M. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia. Drug Safety 2000; 23: 183-95.